Fructose drives colorectal cancer progression by regulating crosstalk between cancer-associated fibroblasts and tumour cells
Abstract
Background Fructose has been identified as a potential alternative energy source for cancer cells, facilitated by the fructose-specific transporter GLUT5. Elevated GLUT5 expression in cancer cells has been associated with increased tumour aggressiveness. However, the role of fructose in remodelling the tumour microenvironment, particularly in modulating cancer-associated fibroblast (CAF) behaviour, remains underexplored. Objective This study aimed to elucidate the regulatory effects and molecular mechanisms of fructose-mediated CAF reprogramming in colorectal cancer (CRC) progression. Design The effects of fructose and fructose-cultured tumour cells on biological function of CAFs were detected. Metabolomics and transcriptomic analyses were used to characterise the fructose-regulated crosstalk network of tumour cells and CAFs. Furthermore, the relationships between GLUT5 expression level in CAFs and clinicopathological features and prognosis of patients with CRC were analysed. Results We demonstrate that fructose plays a dual role in promoting CRC progression by influencing both tumour cells and CAFs. GLUT5 is expressed in both CRC cells and CAFs, with its expression correlating with more advanced tumour stages and poorer outcomes in patients. Fructose metabolism in CAFs enhances their proliferation, migration and activation, while fructose utilisation by CRC cells leads to the release of nucleotides and amino acids. These metabolites activate CAFs and upregulate the expression of the chemokine CXCL14. This, in turn, promotes tumour cell migration and metastasis. Conclusions These findings reveal a novel mechanism by which fructose fosters tumour progression through the modulation of tumour-stroma interactions, and highlight the therapeutic potential of targeting fructose metabolism in CRC to disrupt the tumour-stroma crosstalk that drives malignancy.Keywords
Funding Information
- Tianjin Municipal Science and Technology Committee (20JCZDJC00030)
- Changjiang Scholars and Innovative Research Team (IRT_14R40)
- Tianjin Key Medical Discipline (Specialty) Construction Project (TJYXZDXK-009A)
- National Natural Science Foundation of China (82073085)
- National Natural Science Foundation of China (82073252)
- National Natural Science Foundation of China (82203687)
- National Natural Science Foundation of China (82472996)
This publication has 61 references indexed in Scilit:
- Tryptophan 2,3‐dioxygenase‐positive matrix fibroblasts fuel breast cancer lung metastasis via kynurenine‐mediated ferroptosis resistance of metastatic cells and T cell dysfunctionCancer Communications, 2024
- KHK-A promotes fructose-dependent colorectal cancer liver metastasis by facilitating the phosphorylation and translocation of PKM2Acta Pharmaceutica Sinica B, 2024
- Tumor cell-intrinsic epigenetic dysregulation shapes cancer-associated fibroblasts heterogeneity to metabolically support pancreatic cancerCancer Cell, 2024
- Epithelial cells activate fibroblasts to promote esophageal cancer developmentCancer Cell, 2023
- What is cancer metabolism?Cell, 2023
- Lipid metabolism in pancreatic cancer: emerging roles and potential targetsCancer Communications, 2022
- Spatially organized multicellular immune hubs in human colorectal cancerCell, 2021
- Single-Cell Analyses Inform Mechanisms of Myeloid-Targeted Therapies in Colon CancerCell, 2020
- GLUT5 increases fructose utilization and promotes tumor progression in gliomaBiochemical and Biophysical Research Communications, 2018
- Enhanced Fructose Utilization Mediated by SLC2A5 Is a Unique Metabolic Feature of Acute Myeloid Leukemia with Therapeutic PotentialCancer Cell, 2016